Long-Term Outcomes of Kidney Donors with Nephrolithiasis
Mayo Clinic, Rochester, MN
Meeting: 2020 American Transplant Congress
Abstract number: D-042
Keywords: Living donor
Session Information
Session Name: Poster Session D: Kidney Living Donor: Long Term Outcomes
Session Type: Poster Session
Date: Saturday, May 30, 2020
Session Time: 3:15pm-4:00pm
Presentation Time: 3:30pm-4:00pm
Location: Virtual
*Purpose: Long-term outcomes data of living kidney donors (LKDs) with nephrolithiasis are limited. We assessed the clinical and structural findings and their association with long-term outcomes among LKDs with nephrolithiasis.
*Methods: We performed a multicenter study of LKDs who underwent donor nephrectomy from 1999-2012 with baseline CT scan and implantation biopsy. LKDs ≥ 5 years since donation underwent chart review or completed a long-term follow-up survey for assessment of long-term kidney function – follow-up eGFR by CKD-EPI, residual eGFR (follow-up eGFR/eGFR prior to donation x100%), eGFR <60 and <45 ml/min/BSA - as well as incident (not present prior to donation) hypertension and proteinuria. LKDs with nephrolithiasis (stone formers or SF) were identified by prior history of symptomatic nephrolithiasis (Sx-SF) or by presence of radiographic stone(s) incidentally noted on CT scan during kidney donor evaluation (R-SF). Clinical characteristics, structural findings, and long-term outcomes were compared between SF and non-stone formers (Non-SF) using chi-square or Wilcoxon rank sum test. Univariate and multivariable linear and logistic regression models (with adjustment for age, sex, BMI, and follow-up time) were used to determine the association between stone formation - R-SF only, Sx-SF only, and all SF vs non-SF - and long-term outcomes.
*Results: A total of 866 LKDs (11 Sx-SF, 77 R-SF and 778 Non-SF) were included for analysis. LKDs were 47 +/- 10 years old and 37% male. There were no differences in baseline characteristics between SF and controls. During a median follow-up of 10 (7-12) years, there were no reported adverse renal events (dialysis or listing for transplant). There were no differences in follow-up eGFR, residual eGFR or incident HTN or proteinuria between groups. Multivariable linear regression (Table 1) revealed an association between Sx-SF and higher residual eGFR (p-value=0.0004). There was no association between SF and eGFR <60 or <45, incident HTN, or proteinuria.
*Conclusions: Selected Sx-SF during follow-up may develop higher residual eGFR due to hyperfiltration. Long-term outcomes of selected SF are otherwise similar compared to non-SF.
To cite this abstract in AMA style:
D'Costa MR, Merzkani MA, Denic A, Mullan AF, Larson JJ, Kremers WK, Park WD, Alexander MP, Taler SJ, Issa NS, Stegall MD, Rule AD. Long-Term Outcomes of Kidney Donors with Nephrolithiasis [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/long-term-outcomes-of-kidney-donors-with-nephrolithiasis/. Accessed November 22, 2024.« Back to 2020 American Transplant Congress